Home

General Info

Research Interests

Publications

Teaching2.gif

Tulane Medical School

Hayward Genetics Center

E-Mail



Background

Melanie Ehrlich, Ph.D. (Professor, Dept. of Biochemistry, Human Genetics Program, Tulane Cancer Center) is a molecular biologist studying the role of alterations in mammalian DNA methylation (5-methylcytosine) and chromatin structure in cancer and in a type of inherited muscular dystrophy involving a tandem 3.3-kb DNA repeat.

 

Dr. Ehrlich's lab is studying the involvement of two aspects of epigenetics,
namely, human DNA methylation and chromatin proteins, in carcinogenesis, the
FSHD syndrome (facioscapulohumeral muscular dystrophy), and the ICF syndrome
(immunodeficiency, centromeric region instability, and facial anomalies). This
research focuses on how alterations in chromatin proteins and DNA methylation
occur and affect chromosome stability, long-distance chromatin looping, and
gene expression.


Dr. Ehrlich is a graduate of Columbia University and the State University of New York at Stony Brook and did her postdoctoral research at the Albert Einstein School of Medicine. She was Chairman of the 1998 Gordon Conference on "DNA Alterations in Transformed Cells" and the 1997 FASEB Conference on "Biological Methylation" and founder, former president, and current Vice-President of the DNA Methylation Society, an international society with a lively e-mail network used to exchange scientific information.

Dr. Ehrlich has edited a book entitled "DNA Alterations in Cancer: Genetic and Epigenetic Changes" (Eaton Publishers, 2000). To review its table of contents, click on the book image below:

 

DNA Alterations In Cancer

[Home] [General Info] [Research Interests] [Publications] [Tulane Medical School] [Hayward Genetics Center] [E-Mail]